Arizona bill aims to expand shrinking medical marijuana market
An Arizona bill making its way through the legislature aims to significantly cut the price of medical marijuana…
News June 2
Latest In: Arizona
Cannabis operator Item 9 Labs cutting $3.5M in expenses in restructuring plan
Vertically integrated cannabis producer and retailer Item 9 Labs Corp. has initiated a restructuring plan that includes cutting…
News May 23
Cannabis rebrands aim to differentiate retail, not alienate shoppers
A push toward familiarity and comfort is in - while the reincarnation of the Apple Store for cannabis…
News May 17
Activist cannabis testing labs acquire rivals, increase national reach
Two multistate cannabis testing labs that recently joined forces to establish industry standards are expanding their footprints.
News May 12
POSaBit acquires Hypur’s marijuana e-commerce assets for up to $7.5 million
POSaBit Systems Corp. acquired marijuana e-commerce and compliance software assets from Hypur for as much as $7.5 million…
News April 3
First Arizona cannabis store owned by Black woman to open 4/20
Marijuana entrepreneur Marvina Thomas is the first Black woman to own a legal cannabis store in Arizona.
News March 23
Kris Krane returns to marijuana MSO 4Front Ventures with board seat
Longtime cannabis industry executive Kris Krane is rejoining 4Front Ventures, the multistate marijuana company he co-founded, as a…
News March 16
Tilt Holdings marijuana vape subsidiary Jupiter Research refinances debt
Jupiter Research, a marijuana vape cartridge subsidiary of Phoenix-based Tilt Holdings, refinanced and extended its revolving credit facility.
News March 15
Cannabis brands, products steeped in nostalgia aim to attract generational consumers
Cannabis companies nationwide are infusing a heavy dose of nostalgia in their products and building brands based on…
News March 15
Synthetic cannabinoids further rift between marijuana and hemp industries
A recent ruling from the U.S. Drug Enforcement Administration classifying a synthetic cannabinoid as a Schedule 1 drug…
News March 13
Latest Sponsored
